Yorktown Management & Research Company’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Yorktown Management & Research Company’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-2,000	Closed	-$346K	–	522
2015 Q1	$346K	Hold	2,000	–	–	0.06%	165
2014 Q4	$230K	Hold	2,000	–	–	0.05%	338
2014 Q3	$312K	Sell	2,000 -700	-26%	-$101K	0.06%	148
2014 Q2	$333K	Hold	2,700	–	–	0.06%	154
2014 Q1	$280K	Buy	+2,700	New	+$276K	0.05%	231

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Yorktown Management & Research Company's SLXP Position: Q2 2015 in Review

Yorktown Management & Research Company sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 2,000 shares — an estimated $346K sold.

Yorktown Management & Research Company first reported a position in SLXP in Q1 2014 and held it in 5 quarters. The position peaked at $346K in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Yorktown Management & Research Company reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Yorktown Management & Research Company sold 2,000 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $346K.
Yorktown Management & Research Company first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q1 2014 and held it in 5 quarters.
Yorktown Management & Research Company's SALIX PHARMACEUTICALS LTD DEL position peaked at $346K in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Yorktown Management & Research Company's 13F filing for Q2 2015, filed 22 Jul 2015.